The new neurokinin 1-sensitive receptor mediates the facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after suppression of dopaminergic transmission in the matrix of the rat striatum

Journal of Neurochemistry

Volumn 87, Issue 2, 2003, Pages 487-496

  Kemel, Marie Louise ^a   Pérez, Sylvie ^a   Beaujouan, Jean Claude ^a   Jabourian, Maritza ^a   Soubrié, Philippe ^b   Glowinski, Jacques ^a  

^a INSERM   (France)

^b SANOFI   (France)

Author keywords

ACh release; Matrix compartment; Receptor; Striatum; Subtypes of tachykinin NK1; Suppression of DA transmission; Tachykinin antagonists

Indexed keywords

2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; 2 [[[1 [2 [3,5 BIS(TRIFLUOROMETHYL)PHENYL]ACETYL] 2 (3,4 DICHLOROPHENYL) 2 MORPHOLINYL]ETHYL] 4 PIPERIDINYL] 2 METHYLPROLINAMIDE; ACETYLCHOLINE; METIROSINE; N METHYL DEXTRO ASPARTIC ACID; NEUROKININ; NEUROKININ 1 RECEPTOR; NEUROKININ A; NEUROPEPTIDE K; NOLPITANTIUM; PHYSALAEMIN[9 DEXTRO PROLINE SPIRO GAMMA LACTAM 10 LEUCINE 11 TRYPTOPHAN]; RECEPTOR SUBTYPE; SENKTIDE; SEPTIDE; SERINE; SUBSTANCE P; SUBSTANCE P SULFONE [9 PROLINE]; TACHYKININ; TACHYKININ RECEPTOR; UNCLASSIFIED DRUG; VOFOPITANT;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; EVOKED RESPONSE; EXTRACELLULAR MATRIX; INTERNEURON; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

ACETYLCHOLINE; ALPHA-METHYLTYROSINE; ANIMALS; CORPUS STRIATUM; DOPAMINE; MALE; MORPHOLINES; N-METHYLASPARTATE; PEPTIDE FRAGMENTS; PERFUSION; PIPERIDINES; QUINUCLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2; RECEPTORS, NEUROKININ-3; SUBSTANCE P; SYNAPTIC TRANSMISSION; TACHYKININS; TETRAZOLES;

ANIMALIA;

EID: 0141884371     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.02010.x     Document Type: Article

References (62)

1. 1 receptors. J. Pharmacol. Exp. Ther. 269, 1144-1151.
2. Andrén P. E. and Caprioli R. M. (1995) In vivo metabolism of substance P in rat striatum utilizing microdialysis/liquid chromatography/microelectrospray mass spectrometry. J. Mass Spectrom. 30, 817-824.
3. Aosaki T. and Kawaguchi Y. (1996) Actions of substance P on rat neostriatal neurons in vitro. J. Neurosci. 16, 5141-5153.
4. Aosaki T., Tsubokawa H., Ishida A., Watanabe K., Graybiel A. M. and Kimura M. (1994) Responses of tonically active neurones in the primate's striatum undergo systematic changes during behavioral sensorimotor conditioning. J. Neurosci. 14, 3969-3984.
5. Apicella P., Scarnati E. and Schultz W. (1991) Tonically discharging neurons of monkey striatum respond to preparatory and rewarding stimuli. Exp. Brain Res. 84, 672-675.
6. Arai H. and Emson P. C. (1986) Regional distribution of neuropeptide K and other tachykinins (neurokinin A, neurokinin B and substance P) in rat central nervous system. Brain Res. 399, 240-249.
7. Arenas E., Alberch J., Perez-Navarro E., Solsona C. and Marsal J. (1991) Neurokinin receptors differentially mediate endogenous acetylcholine release evoked by tachykinins in the neostriatum. J. Neurosci. 11, 2332-2338.
8. 1 receptor expression by cholinergic interneurons in human striatum. Neuroreport 5, 1597-1600.
9. Beaujouan J. C., Saffroy M., Torrens Y., Sagan S. and Glowinski J. (1999) Pharmacological characterization of tachykinin 'septide-sensitive' binding sites in the rat submaxillary gland. Peptides 20, 1347-1352.
10. Beaujouan J. C., Saffroy M., Torrens Y. and Glowinski J. (2000) Different subtypes of tachykinin receptor binding sites are present in the rat brain. J. Neurochem. 75, 1015-1026.
11. Besson M. J., Graybiel A. M. and Quinn B. (1990) Co-expression of neuropeptides in the cat's striatum: an immunohistochemical study of substance P, dynorphin B and enkephalin. Neuroscience 39, 33-58.
12. 3H]-acetylcholine in striatal compartments of the rat: regulatory roles of dopamine and GABA. Neuroscience 81, 113-127.
13. 2 (SR48968) tachykinin receptor antagonists of the N-methyl-D-aspartate-evoked release of acetylcholine in striosomes and matrix of the rat striatum. Neuroscience 85, 1025-1036.
14. Bolam J. P. and Bennett B. D. (1995) Microcircuitry of the neostriatum, in Molecular and Cellular Mechanisms of Neostriatal Function (Ariano, M. A., Surmeier, D. J., eds), pp. 1-19. Landes Company, Austin, Texas.
15. Caeser M., Seabrook G. R. and Kemp J. A. (1993) Block of voltage-dependent sodium currents by the substance P receptor antagonist (+/)-CP-96,345 in neurons cultured from rat cortex. Br. J. Pharmacol. 109, 918-924.
16. Calabresi P., Centonze D., Gubellini P., Pisani A. and Bernardi G. (2000) Acetylcholine-mediated modulation of striatal function. Trends Neurosci. 23, 120-126.
17. Cellier E., Barbot L., Iyengar S. and Couture R. (1999) Characterization of central and peripheral effects of septide with the use of five tachykinin NK1 receptor antagonists in the rat. Br. J. Pharmacol. 127, 717-728.
18. Desban M., Kemel M. L., Glowinski J. and Gauchy C. (1993) Spatial organization of patch and matrix compartments in the rat striatum. Neuroscience 57, 661-671.
19. Di Chiara G., Morelli M. and Consomo S. (1994) Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci. 17, 228-233.
20. Diez-Guerra F. J., Sirinathsinghji D. J. S. and Emson P. C. (1988) In vitro and in vivo release of neurokinin A-like immunoreactivity from rat substantia nigra. Neuroscience 27, 527-536.
21. Emonds-Alt X., Doutremepuich J. D., Heaulme M. et al. (1993) In vitro and in vivo biological activities of SR140333, a novel potent nonpeptide tachykinin NK1 receptor antagonist. Eur. J. Pharmacol. 250, 403-413.
22. Emonds-Alt X., Proietto V., Steinberg R. et al. (2002) SSR240600 [(R)2-(1-{2-[3,5-bis(trifluotomethyl)-phenyl]acetyl}-2-(3,4-dichlorphenyl) -2-morpholmyl]ethyl}-4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor. I. Biochemical and pharmacological characterization. JPET 303, 1171-1179.
23. Garret C., Carruette A., Fardin V., Moussaoui S., Peyronel J.-F., Blanchart J.-C. and Laduron P. (1991) Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc. Natl. Acad. Sci. USA 88, 10208-10212.
24. Gerfen C. R. (1991) Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain. Brain Res. 556, 165-170.
25. Gerfen C. R. and Wilson C. J. (1996) The basal ganglia, in Handbook of Chemical Neuroanatomy, Integrated Systems of the CNS, Part III, Vol. 12 (Swanson, L. W., Bjorklund, A., Hokfelt, T., eds), pp. 371-468. Elsevier, Amsterdam.
26. Glowinski J. (1995) The 'septide-sensitive' tachykinin receptor: still an enigmatic story. Trends Pharmacol. Sci. 16, 365-367.
27. Graybiel A. M. (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13, 244-254.
28. Graybiel A. M., Baughman R. W. and Eckenstein F. (1986) Cholinergic neuropil of the striatum observes striosomal boundaries. Nature 323, 625-627.
29. Graybiel A. M., Aosaki T., Flaherty A. W. and Kimura M. (1994) The basal ganglia and adaptative motor control. Science 265, 1826-1831.
30. Guard S., Boyle S. J., Tang K. W., Watling K. J., McKnight A. T. and Woodruff G. N. (1993) The interaction of the NK1 receptor antagonist SP-96,345 with 1-type calcium channels and its functional consequences. Br. J. Pharmacol. 110, 385-391.
31. Guevara-Guzman R., Kendrick K. M. and Emson P. C. (1993) Effect of substance P on acetylcholine and dopamine release in the rat striatum: a microdialysis study. Brain Res. 622, 147-154.
32. Holst B., Hastrup H., Raffetseder U., Martini L. and Schwartz T. W. (2001) Two active molecular phenotypes of the tachykinin NK1 receptor revealed by G-protein fusions and mutagenesis. J. Biol. Chem. 276, 19793-19799.
33. Jakab R. L. and Goldman-Rakic P. (1996a) Presynaptic and postsynaptic subcellular localization of substance P receptor immunoreactivity in the neostriatum of the rat and Rhesus monkey (Macaca mulatta). J. Comp. Neurol. 369, 125-136.
34. Jakab R. L., Hazrati L. and Goldman-Rakic P. (1996b) Distribution and neurochemical character of substance P receptor (SPR)-immunoreactive striatal neurons of the macaque monkey: accumulation of SP fibers and SPR neurons and dendrites in 'striocapsules' encercling striosomes. J. Comp. Neurol. 369, 137-149.
35. Johnson P. J., Bornstein J. C. and Burcher E. (1998) Roles of neuronal NK1 and NK3 receptors in synaptic transmission during motility reflexes in the guinea-pig ileum. Br. J. Pharmacol. 124, 1375-1384.
36. Kaneko T., Shigemoto R., Nakanishi S. and Misumo N. (1993) Substance P receptor-immunoreactive neurons in the rat neostriatum are segregated into somatostatinergic and cholinergic aspiny neurons. Brain Res. 631, 297-303.
37. Kemel M. L., Pérez S., Godeheu G., Soubrié P. and Glowinski J. (2002) Facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after acute and chronic suppression of dopaminergic transmission in the matrix of the rat striatum. J. Neurosci. 22, 1929-1936.
38. Krause J. E., MacDonald M. R. and Takeda Y. (1989) The polyprotein nature of substance P precursors. Bioessays 10, 62-69.
39. Krebs M. O., Trovero F., Desban M., Gauchy C., Glowinski J. and Kemel M. L. (1991) Distinct presynaptic regulation of dopamine release through NMDA receptors in striosome- and matrix-enriched areas of the rat striatum. J. Neurosci. 11, 1256-1262.
40. Lavielle S., Chassing G., Julien S., Marquet A., Bergström L., Beaujouan J. C., Torrens Y. and Glowinski J. (1986) Specific recognition of SP or NKB receptors by analogues of SP substituted at positions 8 and 9. Eur. J. Pharmacol. 125, 461-462.
41. Lindefors N., Brodin E., Tossman U., Segovia J. and Ungerstedt U. (1989) Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation. Exp. Brain Res. 74, 527-534.
42. Maggi C. A. and Schwartz T. W. (1997) The dual nature of the tachykinin NK1 receptor. Trend Pharmacol. Sci. 18, 351-354.
43. Maubach K. A. and Jones R. S. G. (1997) Electrophysiological characterization of tachykinin receptors in the rat nucleus of the solitary tract and dorsal motor nucleus of the vagus in vitro. Br. J. Pharmacol. 122, 1151-1159.
44. Mazzone S. B. and Geraghty D. P. (2000) Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists. Br. J. Pharmacol. 129, 1121-1131.
45. Meini S., Patacchini R. and Maggi C. A. (1994) Tachykinin NK1 receptor subtypes in the rat urinary bladder. Br. J. Pharmacol. 111, 739-746.
46. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney, Australia.
47. Penny G. R., Wilson C. J. and Kitai S. T. (1988) Relationship of the axonal and dendritic geometry of spiny projection neurons to the compartmental organization of the neostriatum. J. Comp. Neurol. 269, 275-289.
48. Petitet F., Beaujouan J. C., Saffroy M., Torrens Y., Chassing G., Lavielle S., Besseyre J., Garret C., Carruette A. and Glowinski J. (1991a) Further demonstration that [Pro9]-substance P is a potent and selective ligand of NK-1 tachykinin receptor. J. Neurochem. 56, 879-889.
49. 1 receptors. Eur. J. Pharmacol. 192, 203-204.
50. Petitet F., Saffroy M., Torrens Y., Lavielle S., Chassing G., Loeuillet D., Glowinski J. and Beaujouan J. C. (1992) Possible existence of a new tachykinin receptor subtype in the guinea-pig ileum. Peptides 13, 383-388.
51. Polidori C., Ciccocioppo R., De Caro G. and Massi M. (1998) Further evidence that central tachykinin NK-1 receptors mediate the inhibitory effect of tachykinins on angiotensin-induced drinking in rats. Peptides 19, 149-155.
52. Prat A., Picard P. and Couture R. (1994) Cardiovascular and behavioural effects of centrally administered neuropeptide K in the rat: receptor characterization. Br. J. Pharmacol. 122, 250-256.
53. Raz A., Frechter-Mazar V., Feingold A., Abeles M., Vaadia E. and Bergman H. (2001) Activity of pallidal and striatal tonically active neurons is correlated in mptp-treated monkeys but not in normal monkeys. J. Neurosci. 21, RC128 (1-5).
54. Rupniak N. M., Boyce S., Williams A. R., Cook G., Longmore J., Seabrook G. R., Caes M., Iversen S. D. and Hill R. G. (1993) Antinociceptive activity of NK1 receptor antagonists: non-specific effects of racemic RP67580. Br. J. Pharmacol. 110, 1607-1613.
55. Sagan S., Karoyan P., Chassing G. and Lavielle S. (1999) Further delineation of the two binding sites (R*(n)) associated with tachykinin neurokinin-1 receptors using [3-prolinomethionine(11)]SP analogues. J. Biol. Chem. 274, 23770-23776.
56. 3H-acetylcholine release evoked by excitatory amino acids. Nature 297, 422-424.
57. Steinberg R., Rodier D., Souilhac J., Bougault I., Emonds-Alt X., Soubrié P. and Le Fur G. (1995) Pharmacological characterization of tachykinin receptors controlling acetylcholine release from rat striatum: an in vivo microdialysis study. J. Neurochem. 65, 2543-2548.
58. Steinberg R., Souilhac J., Rodier D., Alonso X., Emonds-Alt X., Le Fur G. and Soubrié P. (1998) Facilitation of striatal acetylcholine release by dopamine D1 receptor stimulation: involvement of enhanced nitric oxide production via neurokinin-2 receptor activation. Neuroscience 84, 511-518.
59. Steinberg R., Alonso R., Rouquier L. et al. (2002) SSR240600 [(R)-2-(1{2-[3,5-bis(trifluotomethyl)-phenyl]acetyl)-2-(3,4-dichlorophenyl) -2-morpholinyl]ethyl}-4-piperidinyl)-2-methylpropanamide] a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor. II. Neurochemical and behavioral characterization. JPET 303, 1180-1188.
60. Torrens Y., Saffroy M., Glowinski J. and Beaujouan J. C. (1997) Substance P (6-11) and natural tachykinins interact with septide-sensitive tachykinin receptors coupled to a phospholipase C in the rat urinary bladder. Neuropeptides 31, 243-251.
61. Tschöpe C., Jost N., Unger T. and Culman J. (1995) Central cardiovascular and behavioral effects of carboxy- and amino-terminal fragments of substance P in conscious rats. Brain Res. 690, 15-24.
62. Valentino K. L., Tatemoto K., Hunter J. and Barchas J. D. (1986) Distribution of neuropeptide K-immunoreactivity in the rat central nervous system. Peptides 7, 1043-1059.